Corlanor (ivabradine) NDC 55513-813

NDC codes

FDA NDC Directory

Product NDC (as listed)55513-813Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55513-0813Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55513-813-28	55513081328	28 AMPULE in 1 CARTON (55513-813-28) / 5 mL in 1 AMPULE (55513-813-01)Marketed from Apr 19, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Corlanor
Generic name (nonproprietary): ivabradine
Active ingredients: Ivabradine hydrochloride — 5 mg/5mL
Dosage form: Solution
Route: Oral
Labeler: Amgen Inc
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 209964
Marketing start: Apr 19, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists (Mechanism)
Identifiers: Product ID 55513-813_8ab000cd-0258-489a-b1bb-4cc1ca359d6cSPL ID 8ab000cd-0258-489a-b1bb-4cc1ca359d6cSPL set ID 92018a65-38f6-45f7-91d4-a34921b81d0dRxCUI 1649485, 1649491, 1649493, 1649495, 2168592, 2168596UNII TP19837BZKUPC 0355513800600, 0355513810609
Pharmacologic class: Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455513081328 followed by a unit qualifier and the quantity

Package 55513-0813-28. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 10, 2025.

Indications (excerpt from the label)

1. INDICATIONS AND USAGE Corlanor (ivabradine) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker indicated: To reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular ejection fraction. ( 1.1 ) For the treatment of stable symptomatic heart failure due to dilated cardiomyopathy in pediatric patients ages 6 months and older. ( 1.2 ) 1.1 Heart Failure in Adult Patients Corlanor is indicated to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with left ventricular ejection fraction ≤ 35%, who ar…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)